Divergence by ADHD Subtype in Smoking Cessation Response to OROS-Methylphenidate

Nicotine and Tobacco Research - United Kingdom
doi 10.1093/ntr/ntr087
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Impact of Long-Term Treatment With OROS Methylphenidate on Pubertal Development in Adolescents With ADHD

Open Journal of Psychiatry
2014English

Dopamine Transporter Occupancy by Methylphenidate and Impulsivity in Adult ADHD

British Journal of Psychiatry
MedicinePsychiatryMental Health
2014English

Social Adjustment and Family Function After Drug Switch From IR -Methylphenidate to OROS-methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder

Neuropsychiatric Disease and Treatment
2018English

Lower Risk of Fractures Under Methylphenidate Treatment for ADHD: A Dose-Response Effect

Journal of Orthopaedic Research
OrthopedicsSports Medicine
2018English

Smoking Cessation

JAMA - Journal of the American Medical Association
Medicine
2007English

Smoking Status Confirmation by Proxy: Validation in a Smoking Cessation Trial

Nicotine and Tobacco Research
EnvironmentalPublic HealthOccupational Health
2015English

Smoking Cessation in Scotland

Vital
2004English

Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region

Nicotine and Tobacco Research
EnvironmentalPublic HealthOccupational Health
2015English

Determinants of Smoking Cessation and Abstinence in a Russian Smoking-Cessation Center

Tobacco Prevention & Cessation
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy